The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
A | Alimentary tract and metabolism | |
2
|
A03 | Drugs for functional gastrointestinal disorders | |
3
|
A03A | DRUGS FOR FUNCTIONAL BOWEL DISORDERS | |
4
|
A03AB | Synthetic anticholinergics, quaternary ammonium compounds | |
5
|
A03AB06 | Otilonium bromide |
| Active Ingredient |
|---|
|
Otilonium bromide is endowed with a marked spasmolytic action on the smooth muscle of the digestive tract. Otilonium bromide acts predominantly by modifying Ca2+ ion fluxes from cellular and extracellular sites and therefore reduces the trigger of contractile activity and visceral pain, most likely through the inhibition of L- and T-type Ca-channels into intestinal smooth muscle cells and peripheral sensory neurons, respectively. Additionally pharmacological effects could be exerted through the interaction with NK1 and NK2 tachykinin receptors. |
| Document | Type | Information Source | |
|---|---|---|---|
| SPASMOMEN Film-coated tablet | MPI, EU: SmPC | Medicines Authority (MT) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.